- High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer. Cagnoni, P.J., Nieto, Y., Shpall, E.J., Bearman, S.I., Barón, A.E., Ross, M., Matthes, S., Dunbar, S.E., Jones, R.B. J. Clin. Oncol. (1998)